SGH

Sivik Global Healthcare Portfolio holdings

AUM $205M
1-Year Est. Return 28.16%
This Fund
S&P 500
This Quarter Est. Return
1 Year Est. Return
+28.16%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$205M
AUM Growth
+$14.3M
Cap. Flow
Cap. Flow %
Top 10 Hldgs %
Holding
65
New
Increased
Reduced
Closed

Top Buys

1
+$4.19M
2
+$3.84M
3
+$3.81M
4
AZN icon
AstraZeneca
AZN
+$3.51M
5
BIIB icon
Biogen
BIIB
+$3.27M

Top Sells

1
+$4.64M
2
+$4.04M
3
+$3.94M
4
WST icon
West Pharmaceutical
WST
+$3.94M
5
DGX icon
Quest Diagnostics
DGX
+$3.81M

Sector Composition

1 Healthcare 86.61%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
NVO icon
26
Novo Nordisk
NVO
$174B
$3.82M 1.86%
+75,000
AZN icon
27
AstraZeneca
AZN
$306B
$3.68M 1.8%
+40,000
BIO icon
28
Bio-Rad Laboratories Class A
BIO
$7.53B
$3.64M 1.78%
12,000
+1,000
BIIB icon
29
Biogen
BIIB
$27.6B
$3.52M 1.72%
+20,000
GMED icon
30
Globus Medical
GMED
$12.1B
$3.49M 1.7%
+40,000
MRK icon
31
Merck
MRK
$287B
$3.16M 1.54%
+30,000
SGRY icon
32
Surgery Partners
SGRY
$1.83B
$3.09M 1.51%
200,000
-20,000
GILD icon
33
Gilead Sciences
GILD
$180B
$3.07M 1.5%
+25,000
BRKR icon
34
Bruker
BRKR
$5.86B
$3.06M 1.5%
65,000
+5,000
EW icon
35
Edwards Lifesciences
EW
$48.7B
$2.98M 1.46%
+35,000
GEHC icon
36
GE HealthCare
GEHC
$35.1B
$2.87M 1.4%
35,000
+10,000
SEM icon
37
Select Medical
SEM
$2.02B
$2.82M 1.38%
190,000
+15,000
TECH icon
38
Bio-Techne
TECH
$8.74B
$2.65M 1.29%
+45,000
CGON icon
39
CG Oncology
CGON
$5.1B
$1.45M 0.71%
+35,000
ARGX icon
40
argenx
ARGX
$45.1B
$1.26M 0.62%
+1,500
ALNY icon
41
Alnylam Pharmaceuticals
ALNY
$42.5B
$1.19M 0.58%
+3,000
DGX icon
42
Quest Diagnostics
DGX
$22.4B
– –
-20,000
CI icon
43
Cigna
CI
$74.1B
– –
-14,000
JNJ icon
44
Johnson & Johnson
JNJ
$577B
– –
-25,000
LH icon
45
Labcorp
LH
$22.7B
– –
-10,000
STVN icon
46
Stevanato
STVN
$4.34B
– –
-85,000
WST icon
47
West Pharmaceutical
WST
$17.6B
– –
-15,000
ZBH icon
48
Zimmer Biomet
ZBH
$18.3B
– –
-40,000
1
2